Rank |
Score |
Grant Number |
PI Name |
Project Title |
1 |
24 |
5U19DA012043-040001 |
BALL, WILLIAM |
ANTIBODY CHARACTERIZATION |
2 |
24 |
5R03DA013590-02 |
KANTAK, KATHLEEN |
NEW METHOD FOR STUDYING DRUG SELF ADMINISTRATION IN MICE |
3 |
24 |
1R03DA015202-01 |
KHROYAN, TALINE |
Nicotine Self Administration in Mice |
4 |
19 |
2R01DA011742-04 |
WORLEY, PAUL |
Effector IEG, Homer and Drug Addiction |
5 |
16 |
1R21DA014184-01 |
KORNETSKY, CONAN |
DRUGS OF ABUSE AND BRAIN STIMULATION REWARD IN THE MOUSE |
6 |
16 |
1Z01MH000889-22 |
SMITH, CAROLYN |
Studies On Protein Synthesis And Amino Acid Compartmenta |
7 |
14 |
5R01DA010913-05 |
BELKNAP, JOHN |
GENE MAPPING FOR SENSITIVITY TO COCAINE AND AMPHETAMINE |
8 |
14 |
5R01DA011530-04 |
CARROLL, FRANK |
NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE |
9 |
14 |
2R01DA008648-06A2 |
KOSOFSKY, BARRY |
Cocaine-Induced Disturbances of Mouse Brain Development |
10 |
14 |
2R01DA011165-07 |
LEVITT, PAT |
Brain Structure & Function after Fetal Cocaine Exposure |
11 |
14 |
5R01DA013792-02 |
LEVITT, PAT |
FETAL COCAINE AND GENE EXPRESSION DEFECTS IN FOREBRAIN |
12 |
14 |
1R21DA014185-01 |
MIDDAUGH, LAWRENCE |
Cocaine Self Administration and Relapse in Mice:Gene del |
13 |
14 |
1R01DA014644-01 |
XU, MING |
Molecular Determinants of Compulsive Cocaine-Taking |
14 |
10 |
5R01HL063128-02 |
AGRAWAL, KRISHNA |
MECHANISMS OF CARDIOVASCULAR COMPLICATIONS IN AIDS |
15 |
10 |
5R01HL063067-03 |
BAUER, JOHN |
COCAINE AND CARDIOVASCULAR DYSFUNCTION IN MURINE AIDS |
16 |
10 |
5R01DA003742-16 |
BIDLACK, JEAN |
PARTIAL OPIOIDS--POTENTIAL TREATMENTS FOR COCAINE ABUSE |
17 |
10 |
5R01DA011649-02 |
BLENDY, JULIE |
GENETIC ANALYSIS OF DRUG ADDICTION |
18 |
10 |
2P01DA010044-069001 |
CZERNIK, ANDREW |
CORE B - SCIENTIFIC CORE |
19 |
10 |
5R01DA013232-02 |
HIROI, NOBORU |
INTRACELLULAR MOLECULES OF NICOTINE ADDICTION |
20 |
10 |
5R01DA000346-26 |
KARLER, RALPH |
BEHAVIORAL SENSITIZATION--COCAINE AND AMPHETAMINE |
21 |
10 |
5U19DA012043-04 |
NORMAN, ANDREW |
PASSIVE IMMUNITY TO COCAINE USING NOVEL HUMAN ANTIBODIES |
22 |
10 |
5R01DA008254-08 |
TASHKIN, DONALD |
COCAINE SMOKING EFFECTS ON LUNG IMMUNITY & HOST DEFENSE |
23 |
10 |
5R01DA011177-04 |
TECOTT, LAURENCE |
SEROTONIN 5HT2C RECEPTORS AND THE ACTIONS OF COCAINE |
24 |
10 |
5R01DA012180-03 |
WENTLAND, MARK |
AMINOBENZOMORPHAN: POTENTIAL COCAINE ABUSE MEDICATIONS |
25 |
10 |
5K05DA000456-02 |
WHITE, FRANCIS |
COCAINE ADDICTION AND NEURONAL EXCITABILITY |
26 |
10 |
1R21DA014198-01 |
WHITE, FRANCIS |
Mouse Behavior Models of Cocaine Addiction |
27 |
10 |
1Z01DA000445-01 |
WISE, ROY |
Brain Temperature, Reward, And Drugs Of Abuse |
28 |
10 |
5R01DA010309-06 |
WORLEY, PAUL |
ANALYSIS OF A NOVEL COCAINE INDUCED IMMEDIATE EARLY GENE |
29 |
8 |
5R01DA007390-12 |
BLAKELY, RANDY |
REGULATION OF SEROTONIN TRANSPORTERS |
30 |
8 |
5R21MH062813-02 |
EBERWINE, JAMES |
ROBOTIZED EXPRESSION PROFILING OF MOUSE AMYGDALA |
31 |
8 |
5R01DA012062-04 |
GRANDY, DAVID |
TRANSGENIC MICE FOR STUDYING DRUGS OF ABUSE |
32 |
8 |
5P50AA003510-240026 |
HESSELBROCK, VICTOR |
PILOT STUDIES |
33 |
8 |
3P50AA003510-24S10026 |
HESSELBROCK, VICTOR |
PILOT STUDIES |
34 |
5 |
2P01DA010044-060004 |
ALLEN, PATRICK |
NOVEL MOLECULAR TARGETS FOR DRUG OF ABUSE |
35 |
5 |
5R29DA012142-03 |
CAINE, SIMON |
COCAINE SELF ADMINISTRATION IN DOPAMINE KNOCKOUT MICE |
36 |
5 |
5R01HL064555-03 |
CLARKSON, CRAIG |
MOLECULAR BASIS FOR DRUG INDUCED CARDIOTOXICITY IN AIDS |
37 |
5 |
2P01HD005515-320056 |
CRANDALL, JAMES |
Dopamine in neurogenesis and forebrain development |
38 |
5 |
1R21DA014188-01 |
DUGOVIC, CHRISTINE |
IMPORTANCE OF SLEEP & GENOTYPE IN DRUG ABUSE STUDIES |
39 |
5 |
5P01DA008227-100010 |
DUMAN, RONALD |
NEUROPEPTIDE RECEPTORS AND DRUGS OF ABUSE |
40 |
5 |
5R01DA012449-03 |
DUTTA, ALOKE |
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE |
41 |
5 |
3R01NS041871-01S1 |
EHRLICH, MICHELLE |
ONTOGENY OF NEUROADAPTIVE RESPONSES TO PSYCHOSTIMULANTS |
42 |
5 |
5R01NS041871-02 |
EHRLICH, MICHELLE |
ONTOGENY OF NEUROADAPTIVE RESPONSES TO PSYCHOSTIMULANTS |
43 |
5 |
5R29DA011389-04 |
FLECKENSTEIN, ANNETTE |
METHAMPHETAMINE AND DOPAMINE TRANSPORTERS |
44 |
5 |
3R01DA011552-04S1 |
GATLEY, SAMUEL |
ESTIMATION OF SYNAPTIC DOPAMINE USING PET AND SPECT |
45 |
5 |
1Z01AA000303-02 |
GOLDMAN, DAVID |
Snp Function: In Vitro And In Vivo |
46 |
5 |
2P01DA010044-060002 |
GREENGARD, PAUL |
CASEIN KINASES 1& 2, & DARPP-32/PROTEIN PHOSPHATASE-1 SIGNALING CASCADE |
47 |
5 |
5R01DA009862-06 |
HEN, RENE |
DRUGS OF ABUSE IN SEROTONIN RECEPTORS KNOCKOUT MICE |
48 |
5 |
2R01NS008527-30 |
HESS, GEORGE |
CHEMICAL REACTIONS IN TRANSMISSION OF NERVE IMPULSES |
49 |
5 |
1Z01NS002966-04 |
HYMAN, STEVEN |
Regulation Of Striatal Gene Expression By Dopamine And G |
50 |
5 |
3R01DA008590-07S1 |
JANDA, KIM |
IMMUNOPHARMACOTHERAPY AS A TREATMENT FOR COCAINE ABUSE |
51 |
5 |
1Z01DA000105-12 |
KATZ, JONATHAN |
Pharmacology Of Dopamine Receptor Systems |
52 |
5 |
5K02DA000354-04 |
KOSOFSKY, BARRY |
COCAINE-ALTERED BRAIN GROWTH--DOPAMINE KNOCKOUT ANALYSIS |
53 |
5 |
5P01DA009467-080005 |
KOSOFSKY, BARRY |
Functional Brain Mapping of Cocaine Action |
54 |
5 |
5K05DA000049-24 |
KREEK, MARY |
ADDICTIVE DRUGS--PHARMACOLOGY AND PHYSIOLOGY |
55 |
5 |
5K05DA000418-03 |
KUHAR, MICHAEL |
MECHANISMS OF DRUGS OF ABUSE |
56 |
5 |
3R01DA010732-04A1S1 |
KUHAR, MICHAEL |
CART:A novel cocaine regulated neurochemical |
57 |
5 |
5R03DA013421-02 |
LAHOSTE, GERALD |
GAP JUNCTIONS AND DOPAMINE PLASTICITY |
58 |
5 |
5P01DA011470-030001 |
LEE, NANCY |
Non-opioid dynorphin A restores morphine synergy in tolerant animals |
59 |
5 |
5R01NS037031-04 |
LEVEY, ALLAN |
MONAMINE TRANSPORTERS IN PARKINSONISM |
60 |
5 |
5R01HL065167-03 |
LEWIS, WILLIAM |
CARDIAC DYSFUNCITON, AIDS AND COCAINE |
61 |
5 |
5R01DA002396-20 |
MARTIN, BILLY |
INHALATION OF DRUGS OF ABUSE |
62 |
5 |
5R01DA011979-02 |
MATSUMOTO, RAE |
SIGMA LIGANDS FOR THE TREATMENT OF COCAINE OVERDOSE |
63 |
5 |
3R01DA011979-02S1 |
MATSUMOTO, RAE |
SIGMA LIGANDS FOR THE TREATMENT OF COCAINE OVERDOSE |
64 |
5 |
1R01DA013978-01A1 |
MATSUMOTO, RAE |
Synthesis & Evaluation of Cocaine Antagonists |
65 |
5 |
3R01DA002632-22S1 |
MICZEK, KLAUS |
PSYCHOMOTOR STIMULANTS AND AGGRESSION |
66 |
5 |
5R01DA002632-23 |
MICZEK, KLAUS |
PSYCHOMOTOR STIMULANTS AND AGGRESSION |
67 |
5 |
1R01AA013678-01 |
MILES, MICHAEL |
Microarray Analysis of Acute Ethanol Effects in Brain |
68 |
5 |
5R01DA012774-03 |
MORGAN, JAMES |
MECHANISMS OF COCAINE INDUCED EXACCERBATION OF VIRAL MYO |
69 |
5 |
2P01DA010044-060003 |
NAIRN, ANGUS |
DARPP-16 & DARPP-21 IN MEDIATING THE ACTIONS OF DRUGS OF ABUSE |
70 |
5 |
5K05DA000404-04 |
NESTLER, ERIC |
MOLECULAR STUDIES OF OPIATE AND COCAINE ACTION IN BRAIN |
71 |
5 |
5R01DA014133-02 |
NESTLER, ERIC |
NEUROTROPHIC FACTORS AND DRUGS OF ABUSE |
72 |
5 |
1R01DA014251-01 |
NEUMEYER, JOHN |
Mixed Kappa/Mu Opioids: Synthesis and Evaluation |
73 |
5 |
1Z01DA000389-06 |
NEWMAN, AMY |
Novel Probes For The Dopamine Transporter |
74 |
5 |
5U19DA012043-040002 |
NORMAN, ANDREW |
PRE-CLINICAL ANIMAL TESTING |
75 |
5 |
5R01DA004381-15 |
PETERSON, PHILLIP |
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES |
76 |
5 |
5R29DA010455-06 |
PICCIOTTO, MARINA |
NICOTINE ADDICTION IN MICE LACKING THE NEURONAL NACHR |
77 |
5 |
5R21DA012421-03 |
RASO, VICTOR |
VACCINE TO ELICIT CATALYTIC ANTICOCAINE ANTIBODIES |
78 |
5 |
5R01DA009545-05 |
RUTH, JAMES |
MECHANISMS OF DRUG DEPOSITION IN HAIR |
79 |
5 |
1R01DA013508-01A1 |
SCHWARZSCHILD, MICHAEL |
A2A Adenosine Receptors in Psychostimulant Sensitization |
80 |
5 |
5P01DA008227-109002 |
SELF, DAVID |
CORE--BEHAVIORAL |
81 |
5 |
1R01DK057619-01A1 |
SELL, STEWART |
DIFFERENTIATION OF BLOOD STEM CELLS INTO LIVER CELLS |
82 |
5 |
5R01ES009495-02 |
SELL, STEWART |
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM |
|
|
|
|
|
83 |
5 |
1Z01DA000434-02 |
SHAHAM, YAVIN |
Neurobiology Of Relapse To Heroin And Cocaine |
84 |
5 |
5R01NS038281-02 |
SIEBER-BLUM, MAYA |
MECHANISMS OF SYMPATHETIC NEURON SPECIFICATION |
85 |
5 |
5R01DA012111-04 |
SINGHAL, PRAVIN |
HIV ASSOCIATED NEPHROPATHY IN DRUG ADDICTS |
86 |
5 |
2P01DA010044-060001 |
SNYDER, GRETCHEN |
DRUGS OF ABUSE: ROLE OF Cdk5 IN THE ACTIONS OF PSYCHOSTIMULANTS |
87 |
5 |
5P50DA005130-150010 |
SPANGLER, RUDOLPH |
DRUGS OF ABUSE & POTENTIAL THERAPEUTIC AGENTS--NEUROPEPTIDE MOLECULAR
EFFECTS |
88 |
5 |
1Z01DA000206-16 |
SU, TSUNG |
Biochemical Characterization Of Sigma Receptors |
89 |
5 |
3R41DA013521-01S1 |
TELLA, SRIHARI |
BEHAVIORAL STUDIES ON NOVEL MONOAMINE UPTAKE INHIBITORS |
90 |
5 |
1F32DA014150-01 |
TORRES, GONZALO |
Cell /molecular regulation of human dopamine transporter |
91 |
5 |
1R21DA014189-01 |
TSIBULSKY, VLADIMIR |
Measurement of Priming and Satiety Thresholds in Mice |
92 |
5 |
5P50DA005130-150009 |
UNTERWALD, ELLEN |
DRUGS OF ABUSE AND POTENTIAL THERAPEUTIC AGENTS--EFFECT ON OPIATE
RECEPTORS |
93 |
5 |
5R01DA009580-06 |
UNTERWALD, ELLEN |
COCAINE INDUCED OPIOID, DOPAMINE AND BEHAVIORAL CHANGES |
94 |
5 |
3R01HL063667-02S2 |
WATSON, RONALD |
ALCOHOL INDUCED IMMUNOMODULATION--RETROVIRAL CARDIOPATH |
95 |
5 |
5R01HL063667-03 |
WATSON, RONALD |
ALCOHOL INDUCED IMMUNOMODULATION--RETROVIRAL CARDIOPATH |
96 |
5 |
5R01DA012618-03 |
WHITE, FRANCIS |
PREFRONTAL CORTEX NEUROPHYSIOLOGY AFTER CHRONIC COCAINE |
97 |
5 |
3R01DA010900-04S1 |
WIGHTMAN, ROBERT |
DYNAMICS OF IN VIVO DOPAMINE RELEASE |
98 |
5 |
1P01DA013367-01A10001 |
WILKINS, DIANA |
TOLERANCE INDUCTION |
99 |
5 |
2R01GM038273-15A1 |
WILSON, IAN |
Antibodies as Catalysts |
100 |
5 |
1Z01DA000441-02 |
WISE, ROY |
Dopamine Uptake Mechanisms |
101 |
5 |
1R01DA013683-01 |
WOODS, JAMES |
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE |
102 |
5 |
5K02MH001152-07 |
WORLEY, PAUL |
NOVEL CELLULAR MECHANISMS IN CORTEX DEVELOPMENT |
103 |
5 |
5R01DA013786-02 |
XU, MING |
LONG TERM COCAINE INDUCED CHANGES VIA DOPAMINE RECEPTORS |
104 |
5 |
5R29DA011005-05 |
XU, MING |
C-FOS AND PSYCHOMOTOR STIMULANT ACTIONS |
105 |
5 |
5R29ES007965-05 |
YAN, BINGFANG |
MOLECULAR TOXICOLOGY OF PLACENTAL CARBOXYLESTRASE |
106 |
5 |
5R29DA011284-05 |
ZHANG, JIANHUA |
D1 DOPAMINE RECEPTOR SIGNALING AND EFFECTS OF COCAINE |
107 |
5 |
5R01DA011480-04 |
ZHOU, RENPING |
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS |
108 |
5 |
5P50DA005130-150011 |
ZHOU, YAN |
EFFECTS OF DRUGS OF ABUSE & POTENTIAL THERAPEUTIC AGENTS --EXPRESSION OF
HPA AXIS |
109 |
5 |
1R21DA014169-01 |
ZVARTAU, EDWIN |
INTRAVENOUS SELF-ADMINISTRATION IN DRUG-NAIVE MICE |